<?xml version="1.0"?>
<rdf:RDF
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:vocab="file:///home/yin2/Downloads/d2rq-0.8.1/vocab/"
    xmlns:obo="http://purl.obolibrary.org/obo/"
    xmlns:owl="http://www.w3.org/2002/07/owl#"
    xmlns:db="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf"
    xmlns:map="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#"
    xmlns:d2r="http://sites.wiwiss.fu-berlin.de/suhl/bizer/d2r-server/config.rdf#"
    xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
    xmlns:j.0="obo:"
    xmlns:meta="http://www4.wiwiss.fu-berlin.de/bizer/d2r-server/metadata#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
  xml:base="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#" > 
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3ba41382-b985-40ea-a885-859e72187f3c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a0a14e6a-2070-4ebe-ad26-26c4ae1f7ae8"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000109">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/7afff739-dc80-4d7d-ac70-067ebef8749d">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/1afe1aa8-a7b8-4381-89b6-1116292a02ca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002351">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/16bff675-506b-4357-a4b0-bb0384a993f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e3ccdeac-daf8-49e1-b076-420490555c58">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/4a4da6b9-37c2-41ca-8db7-bdb69c1a57cc"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/ed731be5-ac13-40a3-bee1-393104b90514"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/24f04095-2eea-47c0-9c46-91e73c7c8295"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/fe841db3-1888-483b-b890-5ec48a48a2a4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/c8b4e404-f327-40c7-afd1-b0cc5f40ed0f"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/ca6d5f85-8eba-4e36-8874-4d03d599d6df"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/93907f3e-d9f0-4014-bb61-6adfa6a401a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ca6d5f85-8eba-4e36-8874-4d03d599d6df">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c871a45e-aa5c-44de-b89c-d15fc6e52451">
    <rdf:type rdf:resource="obo:RxNorm_686438"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/e63e7ddd-3107-4324-a73e-36346b6ee5f4"/>
    <rdfs:label>INVEGA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c6b6b1c0-35dd-49a3-985f-54c34a9d1e1c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ded3bbe8-7712-4f34-8c14-664ed37b79a5"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/684362ad-dbad-49d2-ae10-3eb35b160d77"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000124">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_25212">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ded3bbe8-7712-4f34-8c14-664ed37b79a5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/object-drug/c871a45e-aa5c-44de-b89c-d15fc6e52451"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-mass/fe293fec-1e80-479c-976c-64c29203c47b"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-active-ingredient/fce5fc5b-77df-486a-a53d-853003d91c6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/CHEBI_59999">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000187">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000003">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000136">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000039">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8280bf00-379f-4ea0-ac56-e8403f3e9eb9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/93073bf9-2221-4d19-acc1-6902b57cbcc9"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0de1cf0a-6864-48f9-89d6-88b20ad080e9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/fe841db3-1888-483b-b890-5ec48a48a2a4"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/object-drug-role/46c7a53b-e30b-4137-a46e-3a371dcd1be1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000052">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b8e4100b-d00d-499a-a024-b5b8fc90f9ac">
    <obo:OBI_0001937>.2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/eea60bb4-d006-4ecb-8be2-cf2213959755"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fce5fc5b-77df-486a-a53d-853003d91c6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/77fa1a8c-9c6b-44a2-a90a-cf27930dea8b">
    <rdf:type rdf:resource="obo:MeSH_D014635"/>
    <rdfs:label>divalproex sodium</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/1999/02/22-rdf-syntax-ns#type">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4a4da6b9-37c2-41ca-8db7-bdb69c1a57cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5e713c4a-5e31-46c5-b8ce-eb4505bca510">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/4dbbe60d-6c01-413b-8936-0ff66c0f2152"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001933">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/5ee660e2-34a3-478b-a310-9bff1ac360c4">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/e63e7ddd-3107-4324-a73e-36346b6ee5f4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0000125">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/11f1621d-1eda-402d-a57d-4f29300f1624">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/5e713c4a-5e31-46c5-b8ce-eb4505bca510"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/4a4da6b9-37c2-41ca-8db7-bdb69c1a57cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000312">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4478a225-fd6c-4a2c-848b-c7f1d3e811d1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/84f26145-cf39-4fd6-9d00-f7a0f5064f28"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d828ac42-2724-4c79-a6e4-7e1b7e767e2e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0de1cf0a-6864-48f9-89d6-88b20ad080e9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9c6b6dd7-cdb7-4978-a636-c93e3f93e1a9"/>
    <rdfs:label>nefazodone-digoxin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/f10760d9-351f-4618-989b-0003396bf06a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/ca6d5f85-8eba-4e36-8874-4d03d599d6df"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/b8e4100b-d00d-499a-a024-b5b8fc90f9ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1129b05e-daaf-4e83-82e4-ae2b5690bef4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/2000/01/rdf-schema#label">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/322ec1eb-b9f3-4204-b2b3-204a661257e9">
    <rdfs:label>nefazodone-digoxin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/f61b3c3e-17f0-4a52-bc92-0cf80bcc8e99">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/84f26145-cf39-4fd6-9d00-f7a0f5064f28">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/322ec1eb-b9f3-4204-b2b3-204a661257e9"/>
    <rdfs:label>nefazodone-digoxin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1fed5ed8-72b7-4d35-bc71-22b9d1a4c289"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/93907f3e-d9f0-4014-bb61-6adfa6a401a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001938">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/46c7a53b-e30b-4137-a46e-3a371dcd1be1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000013">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ed731be5-ac13-40a3-bee1-393104b90514">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/71946e97-152e-45ca-88fd-296b64545c13">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ad3ad3ca-c2f7-4b77-8c21-7720d5dfbffb"/>
    <rdfs:label>divalproex sodium-INVEGA drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8280bf00-379f-4ea0-ac56-e8403f3e9eb9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000001">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cb840b93-7fa2-410c-9278-21d5ac83c64d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f6a1e491-5e0d-4611-9586-f7c2f9f19df2"/>
    <rdfs:label>29 Percent </rdfs:label>
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002353">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/25585b06-629a-4de8-a710-9b05cb2e37be">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/96a6242b-14fb-4c4e-8844-0db3c78beb5c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/71946e97-152e-45ca-88fd-296b64545c13"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c6b6b1c0-35dd-49a3-985f-54c34a9d1e1c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9b0e1eb0-803c-4c5c-a597-d842f916476a"/>
    <rdfs:label>divalproex sodium-INVEGA interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/93073bf9-2221-4d19-acc1-6902b57cbcc9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/b123c329-636b-4134-8029-4481bde699df">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6bcf94dc-82a5-403d-a860-a434babae476">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/24f04095-2eea-47c0-9c46-91e73c7c8295">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5738de7c-99c1-4000-af92-49ebabbcfa3e">
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-mass/6bcf94dc-82a5-403d-a860-a434babae476"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-active-ingredient/1129b05e-daaf-4e83-82e4-ae2b5690bef4"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/77fa1a8c-9c6b-44a2-a90a-cf27930dea8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-dose-specification/26fda64c-7e16-4414-9abf-9abdaea5e4eb">
    <obo:OBI_0001938 rdf:resource="http://dikb.org/precipitant-value-specification/44bc40b6-6c13-44c8-b166-1561c7d8c958"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/precipitant-mass/6bcf94dc-82a5-403d-a860-a434babae476"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c8b4e404-f327-40c7-afd1-b0cc5f40ed0f">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
    <obo:RO_0002352 rdf:resource="http://dikb.org/object-metabolism/b123c329-636b-4134-8029-4481bde699df"/>
    <rdfs:label>digoxin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7a7a81ad-95f4-43b9-a84a-89ef6ec91c36">
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-measurement-unit-label/f61b3c3e-17f0-4a52-bc92-0cf80bcc8e99"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001937">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-measurement-unit-label/4dbbe60d-6c01-413b-8936-0ff66c0f2152">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/39aedc9d-facf-489e-9031-8474fc4202b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/GO_000B152">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002352">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000969">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/14692b0d-ab82-4594-a0c3-134c7153acfa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-dose-specification/b29c0ef9-671c-4d14-be23-72e72b8adebd">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/object-mass/fe293fec-1e80-479c-976c-64c29203c47b"/>
    <obo:OBI_0001938 rdf:resource="http://dikb.org/object-value-specification/7a7a81ad-95f4-43b9-a84a-89ef6ec91c36"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000969"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DRON_00000028">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fe293fec-1e80-479c-976c-64c29203c47b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f6a1e491-5e0d-4611-9586-f7c2f9f19df2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-chemical-substance/1afe1aa8-a7b8-4381-89b6-1116292a02ca">
    <obo:RO_0002353 rdf:resource="http://dikb.org/object-metabolism/b123c329-636b-4134-8029-4481bde699df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_59999"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ad3ad3ca-c2f7-4b77-8c21-7720d5dfbffb">
    <rdfs:label>divalproex sodium-INVEGA DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/684362ad-dbad-49d2-ae10-3eb35b160d77">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000576">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d828ac42-2724-4c79-a6e4-7e1b7e767e2e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/322ec1eb-b9f3-4204-b2b3-204a661257e9"/>
    <rdfs:label>nefazodone-digoxin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cb840b93-7fa2-410c-9278-21d5ac83c64d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000038"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a0a14e6a-2070-4ebe-ad26-26c4ae1f7ae8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9c6b6dd7-cdb7-4978-a636-c93e3f93e1a9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e3ccdeac-daf8-49e1-b076-420490555c58"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/7d3d4a99-63cc-4d3a-a6e8-f8fde1f733e2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/44bc40b6-6c13-44c8-b166-1561c7d8c958">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-measurement-unit-label/16bff675-506b-4357-a4b0-bb0384a993f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9b0e1eb0-803c-4c5c-a597-d842f916476a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5738de7c-99c1-4000-af92-49ebabbcfa3e"/>
    <obo:RO_0000051 rdf:resource="http://dikb.org/precipitant-drug-role/14692b0d-ab82-4594-a0c3-134c7153acfa"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7d3d4a99-63cc-4d3a-a6e8-f8fde1f733e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-measurement-unit-label/eea60bb4-d006-4ecb-8be2-cf2213959755">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000003"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolism/e63e7ddd-3107-4324-a73e-36346b6ee5f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/GO_000B152"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/96a6242b-14fb-4c4e-8844-0db3c78beb5c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ad3ad3ca-c2f7-4b77-8c21-7720d5dfbffb"/>
    <rdfs:label>divalproex sodium-INVEGA drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3ba41382-b985-40ea-a885-859e72187f3c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000046"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1fed5ed8-72b7-4d35-bc71-22b9d1a4c289">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/39aedc9d-facf-489e-9031-8474fc4202b7"/>
    <rdfs:label>15 Percent </rdfs:label>
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-metabolite/0093f44a-f71d-4c65-9598-7da27557ea4b">
    <obo:RO_0000052 rdf:resource="http://dikb.org/object-chemical-substance/5ee660e2-34a3-478b-a310-9bff1ac360c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/CHEBI_25212"/>
  </rdf:Description>
</rdf:RDF>
